Lavoltidine
Lavoltidine (pronounced la-vol-ti-dine) is a histamine antagonist specifically a H2 receptor antagonist that was developed for potential use in the treatment of peptic ulcer disease and gastroesophageal reflux disease (GERD). However, its development was discontinued due to the discovery of adverse effects on the liver.
Etymology
The term "Lavoltidine" is derived from the Latin word "lavolta", meaning "to turn", and the suffix "-tidine", which is commonly used in the names of H2 receptor antagonists.
Pharmacology
Lavoltidine works by blocking the action of histamine on the parietal cells in the stomach, thereby reducing the production of gastric acid. This can help to prevent and heal peptic ulcers and reduce the symptoms of GERD.
Related Terms
- Histamine
- H2 receptor antagonist
- Parietal cells
- Gastric acid
- Peptic ulcer disease
- Gastroesophageal reflux disease
See Also
External links
- Medical encyclopedia article on Lavoltidine
- Wikipedia's article - Lavoltidine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski